Our news

A message from IOPtima’s CEO
Jan
18
Event

A message from IOPtima’s CEO

From the beginning of 2020, we were very busy supporting our partners and promoting our laser technology for glaucoma surgery around the world, with our team participating and training dozens of doctors worldwide – Europe, Asia, and South America – to perform CLASS (CO2 Laser-Assisted Sclerectomy Surgery).
CLASS results from Debrecen Hungary
Jan
18
Clinical Data

CLASS results from Debrecen Hungary

A new article with 1-year results of CLASS was published in the Clinical Ophthalmology, on 22 open-angle glaucomatous (OAG) eyes of patients.
Safe, accurate, efficacious – is CLASS the new NPDS?
Dec
15
Dry Eye

Safe, accurate, efficacious – is CLASS the new NPDS?

Trabeculectomy is a traditional and common surgical intervention for IOP reduction in patients with open-angle glaucoma. CO2 laser-assisted sclerectomy (CLASS) procedures are less common but, according to a recent study, no less effective.
Master CLASS 2020
Dec
15
Glaucoma

Master CLASS 2020

IOPtima presents its new program, the MasterCLASS 2020, in partnership with the Clinic Pasteur in France, the Europeen reference CLASS center and the Dr Antoine Bastelica.

Flash Info

July is Dry Eye Awareness Month, so IOPtima is proud to present the first ads for the only preservative-free lipid-based eye drops, LIPITEAR™ MULTI, that are currently already available in Israel.
We’re pleased to announce that we have appointed Eran Kaplan as new Chief Executive Officer of IOPtima
New article - Why is Dr Roberto Anaya a fan of IOPtima’s iLid CO2 laser for blepharoplasty?

Most popular

Categories

Take your clinic to the next level!
To schedule a demo, contact us.

Contact us

IOPtima is dedicated to improving ophthalmic care through the development and commercialization of innovative products for a wide range of ocular conditions.

IOPtima is a Chengdu Kanghong Pharmaceutical company.

Read More
Our Products
IOPtimate®Fabilas™iLid™Lipitear™
Treatments
GlaucomaEyelid SurgerySkin ResurfacingOcular Surface Disorder
Pitch an Idea

IOPtima, along with our parent company, Kanghong Pharmaceuticals, is working with companies, researchers and doctors around the world with a mission to bring the most advanced, safe and effective products to the ophthalmic community. We invite you to partner with us on this important mission. Contact us if you have an innovative product, idea or are looking to partner for the development or commercialization of your product.

Contact Us
Privacy • Terms • All Right Reserved 2022  • Made by BRACT Agency